Solid Biosciences Inc. — Director's Dealing 2024

Oct 22, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Solid Biosciences Inc. (SLDB)
CIK: 0001707502
Period of Report: 2024-10-18

Reporting Person: Brooks Gabriel (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2024-10-18	Common Stock	M	9750	—	Acquired	13902	Direct
2024-10-21	Common Stock	S	2923	$6.5	Disposed	10979	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2024-10-18	Restricted Stock Units	$	M	9750	Disposed		Common Stock (9750)	Direct

Footnotes

F1: Restricted stock units ("RSUs") convert into common stock on a one-for-one basis.

F2: Includes 4,152 shares of common stock acquired under the Solid Biosciences Inc. Employee Stock Purchase Plan on May 31, 2024.

F3: This sale was made to cover withholding taxes following the vesting of the previously granted RSUs.

F4: The RSUs were granted on October 18, 2023 (the "Grant Date") and vest over four years, with 25% of the original number of shares vesting on each anniversary of the Grant Date until the fourth such anniversary.